Skip to Main Content

Paper Details

The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer.
Clin Cancer Res
10
2022
18F-fluorodeoxyglucose, AKT, Cancer, FDG, Insulin, PI3K, PIK3R1, PTEN, Patients, Prostate Cancer, breast, cancers, cell lines, glucose, human, insulin, mRNA, metastatic cancers, metastatic castration-resistant prostate cancer, metastatic prostate cancer, patient, patients, primary cancers, prostate, prostate cancer, prostate cancer cell lines, prostate cancers, prostate tumors, tumor
Author NameAffiliation
Howard I ScherMemorial Sloan Kettering Cancer Center
Howard I ScherMemorial Sloan Kettering Cancer Center
Michael J MorrisMemorial Sloan Kettering Cancer Center
Wassim AbidaMemorial Sloan Kettering Cancer Center
Jeremy C DurackMemorial Sloan Kettering Cancer Center
Stephen B SolomonMemorial Sloan Kettering Cancer Center
Lorelei A MucciHarvard T.H. Chan School of Public Health
Nikolaus SchultzCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffMemorial Sloan Kettering Cancer Center
  • 1 - 15

Datasets

Release 1.2